Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX3 | P56373 | 5/20 | 0.35 |
| ▸ | P2RX2 | Q9UBL9 | 5/20 | 0.35 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.33 |
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.32 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2271062 | 0.92 | CYP11B1 (0.39) | P2RX3P2RX2 | |
| SCHEMBL2274756 | 0.88 | P2RY14 (0.42) | P2RX3P2RX2P2RY14 | |
| SCHEMBL3720193 | 0.88 | P2RY14 (0.42) | P2RX3P2RX2P2RY14 | |
| SCHEMBL2275029 | 0.80 | — | — | |
| SCHEMBL4178348 | 0.77 | P2RY14 (0.40) | P2RX3P2RX2P2RY14 | |
| SCHEMBL2271968 | 0.75 | P2RX3 (0.66) | P2RX3P2RX2 | |
| SCHEMBL18172405 | 0.73 | P2RX3 (0.47) | P2RX3P2RX2P2RY14 | |
| SCHEMBL2276093 | 0.71 | P2RX3 (0.41) | P2RX3P2RX2 | |
| SCHEMBL4051058 | 0.68 | P2RX3 (0.46) | P2RX3P2RX2P2RY14 | |
| SCHEMBL4177211 | 0.68 | P2RY14 (0.42) | P2RX3P2RX2P2RY14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2225213-A1 | TRIAZOLE-SUBSTITUTED ARYLAMIDE DERIVATIVES AND THEIR USE AS P2X3 AND /OR P2X2/3 PURINERGIC RECEPTOR ANTAGONISTS | F. Hoffmann-La Roche AG (CH) | 2010-09-08 | — | — | EP | disclosed |
| WO-2009077366-A1 | TRIAZOLE-SUBSTITUTED ARYLAMIDE DERIVATIVES AND THEIR USE AS P2X3 AND /OR P2X2/3 PURINERGIC RECEPTOR ANTAGONISTS | F. HOFFMANN-LA ROCHE AG (CH) | 2009-06-25 | — | — | WO | disclosed |